Contact this trialFirst, we need to learn more about you.
Neoantigen DNA vaccine for Breast Cancer
Recruiting1 awardPhase 1
Saint Louis, Missouri
This trial is testing a neoantigen DNA vaccine in patients with triple negative breast cancer. The vaccine will be given either alone or with the drug durvalumab.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.